Uttar Pradesh News Desk

Ewing Sarcoma Epidemiology Forecast Analysis During the Study Period (2018-30) by DelveInsight

 Breaking News
  • No posts were found

Ewing Sarcoma Epidemiology Forecast Analysis During the Study Period (2018-30) by DelveInsight

July 07
22:38 2021
Ewing Sarcoma Epidemiology Forecast Analysis During the Study Period (2018-30) by DelveInsight

Ewing Sarcoma Epidemiology Forecast
DelveInsight’s ‘Ewing Sarcoma – Epidemiology Forecast to 2030’ report provides an in-depth explanation of the disease, as well as historical and anticipated Ewing Sarcoma epidemiology in the 7MM, which includes the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight’s ‘Ewing Sarcoma – Epidemiology Forecast to 2030’ report provides an in-depth explanation of the disease, as well as historical and anticipated Ewing Sarcoma epidemiology in the 7MM, which includes the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the Key Highlights from the Ewing Sarcoma Epidemiology Report

  • According to the Japanese Orthopedic Association (JOA) registry, Ewing Sarcoma is rare in Japanese individuals, with only 30–40 cases occurring each year.

  • Ewing Sarcoma accounts for around 1% of all juvenile malignancies, according to the American Cancer Society. Each year, about 200 adolescents and teenagers in the United States are diagnosed with Ewing Sarcoma.

  • According to DelveInsight, Ewing Sarcoma epidemiology insights, the Ewing Sarcoma incidence is same among boys and girls upto age 10, but later men are more frequently affected to Ewing Sarcoma than women with 3:2 ratio.

For more information on ewing sarcoma epidemiology, request sample @ Ewing Sarcoma Treatment

Ewing Sarcoma: Overview

Ewing sarcoma can be either a bone or a soft-tissue sarcoma. Swelling and pain at the tumor’s site, as well as a fever and a bone fracture, are all possible symptoms. The thighs, pelvis, and chest wall are the most common places where it starts.

Ewing Sarcoma’s exact cause is unknown, and the underlying cell type has not been identified. The majority of cases are thought to occur at random and for no apparent reason (sporadically). According to chromosomal (cytogenetic) studies, Ewing sarcoma cells are frequently characterized by an abnormal change in their genetic makeup known as a reciprocal translocation.

Ewing Sarcoma Epidemiology Segmentation

  • Ewing Sarcoma Incident Cases

  • Ewing Sarcoma Age-Specific Cases

  • Ewing Sarcoma Subtype-Specific Cases

  • Ewing Sarcoma Treatable Cases

  • Ewing Sarcoma Gender-Specific Cases

Want to know the difference between ewing sarcoma and osteosarcoma? Find out @ Ewing Sarcoma vs Osteosarcoma

Table of Contents

1.

Key Insights

2.

Ewing Sarcoma: Market Overview at a Glance

3.

Executive Summary

4.

Organizations

5.

Ewing Sarcoma: Disease Background and Overview

6.

Ewing Sarcoma Epidemiology and Patient Population

7.

SWOT Analysis

8.

Case studies

9.

KOL Views

10.

Appendix

11.

Report Methodology

12.

DelveInsight Capabilities

13.

Disclaimer

14.

About DelveInsight

Related Reports

Osteosarcoma Epidemiology Forecast

DelveInsight’s ‘Osteosarcoma – Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Osteosarcoma, historical and forecasted epidemiology as well as the Osteosarcoma trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Related Post

Ewing Sarcoma Treatment Landscape

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.  

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

Related Articles